Among the isoforms of the catalytic subunit of class I PI3K, p110δ is the most promising target for inhibition in B-ALL given the restricted expression of the p110δ isoform on leukocytes [16] and its important role in B cell signaling [40]. This evidence concerns the gene PIK3CD and precursor B-cell acute lymphoblastic leukemia.